Buda Juice, which makes branded and private label citrus drinks, filed on Wednesday with the SEC to raise up to $22 million in an initial public offering.
Buda Juice states that it is pioneering the "UltraFresh" juice category through its end-to-end cold chain platform. Its product portfolio consists of fresh citrus juices and wellness shots across multiple brand lines and retail customers, which it believes demonstrates both brand diversification and private label manufacturing capabilities. The company currently operates from its Dallas plant but has plans for facilities in South Carolina (2026) and Arizona/Nevada (2027).
The Dallas, TX-based company was founded in 2013 and booked $12 million in sales for the 12 months ended June 30, 2025. It plans to list on either the Nasdaq or the NYSE, and it has not selected a symbol yet (RC ticker: BDJC.RC). MDB Capital Group is the sole bookrunner on the deal. No pricing terms were disclosed.
